REVIEWING THE EFFECTIVENESS OF UK DRUG HORIZON SCANNING EFFORTS & THE PRODUCTION OF NICE COMMENTARY ALONG THERAPEUTIC SPECIALTIES

Author(s)

Woltmann JD
National Institute for Health Research Innovation Observatory, Newcastle upon Tyne, UK

OBJECTIVES: The National Institute for Health Research Innovation Observatory is responsible for notifying the National Institute for Health & Clinical Excellence (NICE) of new drugs & indications prior to market authorisation (MA). This constitutes the first step in NICE's topic selection, and the desired notification period is 600 days for new drugs, 450 for new indications. This research aims to explore the success of previous horizon scanning at meeting notification requirements as well as the speed at which NICE commentary was produced.

METHODS: All publically available NIHR horizon briefs between 2006 and Q12017 were collated and segmented by specialty area. Of the resulting 1060 briefings, 223 were examined across 5 distinct specialties. The product, briefed indication, and notification date were identified, and the pertaining MA status within the United Kingdom and availability of NICE commentary were determined for each product & briefed indication. Resulting notification & commentary time periods were compared across product, specialty and label groups.

RESULTS: CONCLUSIONS: For both new drugs & indications, the average notification period was significantly better than required, but differences between products & specialties indicate that improvements across groups can be made. Likewise, differences in average commentary periods also suggest that efficiencies might be gleaned from certain specialty areas, though the precise cause of these differences (beyond the mere impact of the specialty group) would require further elucidation.

Conference/Value in Health Info

2017-11, ISPOR Europe 2017, Glasgow, Scotland

Value in Health, Vol. 20, No. 9 (October 2017)

Code

PHP246

Topic

Health Technology Assessment

Topic Subcategory

Decision & Deliberative Processes

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×